Antimicrobial susceptibility of 1,422 Haemophilus influenzae isolates from respiratory tract infections in Spain.: Results of a 1-year (1996-97) multicenter surveillance study

被引:21
作者
García-Rodríguez, JA
Baquero, F
de Lomas, JG
Aguilar, L
机构
[1] SmithKline Beecham Pharmaceut, Dept Med, E-28034 Madrid, Spain
[2] Univ Hosp Salamanca, E-37007 Salamanca, Spain
[3] Hosp Ramon & Cajal, E-28034 Madrid, Spain
[4] Inst Valenciano Microbiol, E-46117 Valencia, Spain
[5] Hosp La Paz, Madrid, Spain
[6] Hosp Gen Gregorio Maranon, Madrid, Spain
[7] Xeral Galicia Hosp, Santiago De Compostela, Spain
[8] Virgen Macarena Hosp, Seville, Spain
[9] Clin Univ Hosp, Barcelona, Spain
[10] Univ Hosp Zaragoza, Zaragoza, Spain
[11] Virgen Nieves Hosp, Granada, Spain
[12] Reina Sofia Hosp, Cordoba, Spain
[13] Basurto Hosp, Bilbao, Spain
[14] Univ Hosp Salamanca, Salamanca, Spain
[15] Santa Creu & San Pau Hosp, Barcelona, Spain
[16] Hosp Insular, Las Palmas Gran Canaria, Spain
[17] Infanta Cristina Hosp, Badajoz, Spain
[18] Inst Valenciano Microbiol, Valencia, Spain
[19] SmithKline Beecham Pharmaceut, Madrid, Spain
关键词
Penicillin; Production Rate; Respiratory Tract; Respiratory Tract Infection; Amoxicillin;
D O I
10.1007/s150100050026
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A Haemophilus influenzae multicenter antimicrobial susceptibility surveillance was carried out. An overall beta-lactamase production rate of 25.7% was found, with significant differences between hospitals ranging between 7.9 and 47.9%. Presumable intrinsic resistance was found in 4.6% of strains. No differences in susceptibility were observed between beta-lactamase positive and beta-lactamase negative strains for all antibiotics, except for penicillin, amoxicillin and cefaclor, A higher prevalence of resistance was found for clarithromycin vs azithromycin (22.6 vs 0.7%). Differences in all these factors make surveillance essential as a guideline for empiric treatment in community-acquired respiratory tract infections.
引用
收藏
页码:265 / 267
页数:3
相关论文
共 7 条
[1]   Susceptibility surveillance of US respiratory pathogen isolates to newer macrolide and azalide antibiotics [J].
Barry, S ;
Barry, AL ;
Burton, P .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1996, 7 (01) :53-58
[2]   Clarithromycin and azithromycin [J].
Barza, M ;
Eisenberg, E .
INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1996, 5 (05) :291-302
[3]   Comparative evaluation of orally active antibiotics against community-acquired pathogens: Results of eight European countries [J].
Cullmann, W .
CHEMOTHERAPY, 1996, 42 (01) :11-20
[4]   DISTRIBUTION AND RESISTANCE PATTERNS OF HEMOPHILUS-INFLUENZAE - A EUROPEAN COOPERATIVE STUDY [J].
MACHKA, K ;
BRAVENY, I ;
DABERNAT, H ;
DORNBUSCH, K ;
VANDYCK, E ;
KAYSER, FH ;
VANKLINGEREN, B ;
MITTERMAYER, H ;
PEREA, E ;
POWELL, M .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1988, 7 (01) :14-24
[5]  
National Committee for Clinical Laboratory Standards, 1997, METH DIL ANT SUSC TE
[6]  
NEEDHAM C A, 1988, Clinical Microbiology Reviews, V1, P218
[7]  
PEREA EJ, 1993, ENF INFECC MICROBIOL, V11, P31